65 /100
HIGH RISK
Score updated Apr 28, 2026

OTLC

Oncotelic Therapeutics, Inc. — Stock Dilution Tracker

Track OTLC dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

🔔 Track OTLC — Get alerts when the score changes →
📊 Score Breakdown
📋 Offering Ability
40
💰 Cash Runway
95
📊 Float Risk
32
⚠️ Warrant Exposure
15
🔄Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
53%
🔄 Reverse Split 70%
• 50-day avg $0.04 below $1 exchange minimum
• Only 1 months cash — financial pressure
💰 Capital Raise 55%
• Critical: only 1.0 months cash remaining
📉 Score Deterioration 10%
• Score in HIGH risk zone (65/100)
🔔 Track OTLC — Get forecast alerts →
💹 Market Data
Market Cap$15.99M
Shares Outstanding444.20M
Float228.62M
Cash$88.9K
Debt$13.91M
Short InterestN/A
🏛 Institutional Holdings
Institutional data not yet available.
📉 Short Interest
Short Interest16
Days to Cover1.0
% of FloatN/A
FINRA data as of Apr 15, 2026
📁 Recent SEC Activity
xbrl XBRL CONVERTIBLE Dec 31, 2025
xbrl XBRL WARRANT Sep 30, 2024
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
Track OTLC Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking OTLC — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: AURX BCTX CDT CHRS COOT
🔬 More Research for OTLC
📊 OTLC FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 OTLC Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.